{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:14Z","timestamp":1794019634230,"version":"4.8.0"},"reference-count":53,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Visceral leishmaniasis caused by Leishmania donovani is one of the major neglected tropical diseases attributable to parasitic protozoa. In the absence of an effective vaccine, chemotherapy remains the only available therapeutic option. However, current treatments rely on a limited number of drugs that are largely obsolete, highly toxic or require intravenous administration, and their extensive use has led to the emergence of drug resistance. Consequently, the discovery of new antileishmanial agents is an urgent priority. In this study, a commercial library of 449 alkaloids in a high-throughput screening format was evaluated against both axenic bone marrow-derived amastigotes and intramacrophagic amastigotes from mice infected with L. donovani IRFP, a strain engineered to emit infrared fluorescence in its viable form. Six isoquinoline-type alkaloids showed the best antileishmanial efficacy against intramacrophagic amastigotes while exhibiting minimal cytotoxicity toward RAW 264.7 and HepG2 cell lines, with a promising selective index higher than four, and good mouse intestinal tolerance in mouse organoids. Among these compounds, the protoberberine scaffold emerged as the most promising candidate for further drug development.<\/jats:p>","DOI":"10.3390\/molecules30214210","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:26:29Z","timestamp":1761711989000},"page":"4210","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-7540","authenticated-orcid":false,"given":"Cathy","family":"Soh-Kamdjo","sequence":"first","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1069-3940","authenticated-orcid":false,"given":"Mar\u00eda-Cristina","family":"Gonz\u00e1lez-Montero","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9669","authenticated-orcid":false,"given":"Carlos","family":"Garc\u00eda-Estrada","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-060X","authenticated-orcid":false,"given":"Estela","family":"Melc\u00f3n-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-8121","authenticated-orcid":false,"given":"Celia","family":"Fern\u00e1ndez-Rubio","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-3785","authenticated-orcid":false,"given":"Yolanda","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-2997","authenticated-orcid":false,"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-6116","authenticated-orcid":false,"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Biom\u00e9dicas, Facultad de Veterinaria, Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"},{"name":"Instituto de Biomedicina (IBIOMED), Universidad de Le\u00f3n, Campus de Vegazana s\/n, 24007 Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2020). Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021\u20132030, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hietanen, H., Pfavayi, L.T., and Mutapi, F. (2025). Unlocking the blueprint to eliminating neglected tropical diseases: A review of efforts in 50 countries that have eliminated at least 1 NTD. PLoS Negl. Trop. Dis., 19.","DOI":"10.1371\/journal.pntd.0013424"},{"key":"ref_3","unstructured":"(2025, September 01). DNDi-Annual Report 2024. Available online: https:\/\/dndi.org\/wp-content\/uploads\/2025\/07\/DNDi-AnnualReport-2024.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis: Current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_6","first-page":"653","article-title":"Global leishmaniasis surveillance updates 2023: 3 years of the NTD road map","volume":"45","author":"Jain","year":"2024","journal-title":"Wkly. Epidemiol. Rec."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/pac-2018-1102","article-title":"Current and promising novel drug candidates against visceral leishmaniasis","volume":"91","author":"Reguera","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. target-based drug discovery for first-in-class medicines","volume":"93","author":"Swinney","year":"2013","journal-title":"Clin. Pharm. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijpddr.2014.05.001","article-title":"Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?","volume":"4","author":"Reguera","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3762\/bjoc.12.267","article-title":"Computational methods in drug discovery","volume":"12","author":"Leelananda","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ddtec.2021.08.001","article-title":"From computer-aided drug discovery to computer-driven drug discovery","volume":"39","author":"Frye","year":"2021","journal-title":"Drug Discov. Today Technol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_13","first-page":"401","article-title":"Natural alkaloids: Basic aspects, biological roles, and future perspectives","volume":"12","author":"Qiu","year":"2014","journal-title":"Chin. J. Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.jnatprod.8b00159","article-title":"Active natural product scaffolds against trypanosomatid parasites: A review","volume":"81","author":"Cockram","year":"2018","journal-title":"J. Nat. Prod."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Daley, S.K., and Cordell, G.A. (2021). Alkaloids in contemporary drug discovery to meet global disease needs. Molecules, 26.","DOI":"10.3390\/molecules26133800"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1386207319666160506123921","article-title":"Natural products as a source for antileishmanial and antitrypanosomal agents","volume":"19","author":"Scotti","year":"2016","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Calvo-\u00c1lvarez, E., Stamatakis, K., Punz\u00f3n, C., \u00c1lvarez-Velilla, R., Tejer\u00eda, A., Escudero-Mart\u00ednez, J.M., P\u00e9rez-Pertejo, Y., Fresno, M., Bala\u00f1a-Fouce, R., and Reguera, R.M. (2015). Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003666"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: An open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chembiol.2021.01.010","article-title":"The future of phenotypic drug discovery","volume":"28","author":"Berg","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00284-012-0209-1","article-title":"Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds","volume":"65","author":"Ravinder","year":"2012","journal-title":"Curr. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.drudis.2006.06.014","article-title":"Targeting atypical trypanosomatid DNA topoisomerase I","volume":"11","author":"Redondo","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_25","unstructured":"(2025, September 01). DNDi. Available online: https:\/\/dndi.org\/diseases\/visceral-leishmaniasis\/projects-achievements\/."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yaluff, G., Herrera, L., Rol\u00f3n, M.S., Vega, C., and Cerecetto, H. (2025). The quinoline framework and related scaffolds in natural products with anti-Leishmania properties. Front. Chem., 13.","DOI":"10.3389\/fchem.2025.1571067"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: Practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/np0702281","article-title":"Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida","volume":"70","author":"Fotie","year":"2007","journal-title":"J. Nat. Prod."},{"key":"ref_29","first-page":"1181","article-title":"Research progress on natural benzophenanthridine alkaloids and their pharmacological functions: A review","volume":"11","author":"Han","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Peng, R., Xu, M., Xie, B., Min, Q., Hui, S., Du, Z., Liu, Y., Yu, W., Wang, S., and Chen, X. (2023). Insights on antitumor activity and mechanism of natural benzophenanthridine alkaloids. Molecules, 28.","DOI":"10.3390\/molecules28186588"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1248\/cpb.58.1047","article-title":"In vitro leishmanicidal activity of benzophenanthridine alkaloids from Bocconia pearcei and related compounds","volume":"58","author":"Fuchino","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0034-1382826","article-title":"In vitro and in vivo activity of benzo[c]phenanthridines against Leishmania amazonensis","volume":"80","author":"Castillo","year":"2014","journal-title":"Planta Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11686-024-00977-x","article-title":"The potential role of sanguinarine as an inhibitor of leishmania pp2c in the induction of apoptosis","volume":"70","year":"2025","journal-title":"Acta Parasitol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00436-018-6157-3","article-title":"Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria","volume":"118","author":"Sarkar","year":"2019","journal-title":"Parasitol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/10715760903186124","article-title":"Berberine chloride causes a caspase-independent, apoptotic-like death in Leishmania donovani promastigotes","volume":"43","author":"Saha","year":"2009","journal-title":"Free Radic. Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Saha, P., Bhattacharjee, S., Sarkar, A., Manna, A., Majumder, S., and Chatterjee, M. (2011). Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018467"},{"key":"ref_37","first-page":"805","article-title":"Antileishmanial potential of berberine alkaloids from berberis glaucocarpa roots: Molecular docking suggests relevant leishmania protein targets","volume":"16","author":"Alamzeb","year":"2021","journal-title":"Nat. Prod. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114013","DOI":"10.1016\/j.phytochem.2024.114013","article-title":"Isolation, characterization and anti-inflammatory effect of alkaloids from the roots of Stemona tuberosa Lour","volume":"220","author":"Zhang","year":"2024","journal-title":"Phytochemistry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2413676","DOI":"10.1002\/advs.202413676","article-title":"Meisoindigo acts as a molecular glue to target PKMYT1 for degradation in chronic myeloid leukemia therapy","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/mp900243b","article-title":"Cancer therapies utilizing the camptothecins: A review of the in vivo literature","volume":"7","author":"Venditto","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1158\/1078-0432.CCR-19-1089","article-title":"Targeting topoisomerase I in the era of precision medicine","volume":"25","author":"Thomas","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lee, J., Beers, J.L., Geffert, R.M., and Jackson, K.D. (2024). A review of CYP-mediated drug interactions: Mechanisms and in vitro drug-drug interaction assessment. Biomolecules, 14.","DOI":"10.3390\/biom14010099"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0701737104","article-title":"Crystal structure of the chromophore binding domain of an unusual bacteriophytochrome, RpBphP3, reveals residues that modulate photoconversion","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0024-3205(94)00916-3","article-title":"Fluorinated analogues of L-ornithine are powerful inhibitors of ornithine decarboxylase and cell growth of Leishmania infantum promastigotes","volume":"56","author":"Reguera","year":"1995","journal-title":"Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Melc\u00f3n-Fern\u00e1ndez, E., Galli, G., Garc\u00eda-Estrada, C., Bala\u00f1a-Fouce, R., Reguera, R.M., and P\u00e9rez-Pertejo, Y. (2023). Miltefosine and nifuratel combination: A promising therapy for the treatment of Leishmania donovani visceral leishmaniasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021635"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acsinfecdis.1c00139","article-title":"Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis","volume":"7","author":"Reguera","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bcp.2013.04.016","article-title":"Intestinal organoids as tissue surrogates for toxicological and pharmacological studies","volume":"85","author":"Kuratnik","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jmcb\/mjaa036","article-title":"Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening","volume":"12","author":"Du","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13321-021-00526-y","article-title":"\u201cMolecular Anatomy\u201d: A new multi-dimensional hierarchical scaffold analysis","volume":"13","author":"Manelfi","year":"2021","journal-title":"J. Cheminform"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/acsomega.2c07346","article-title":"Cheminformatic analysis and machine learning modeling to investigate androgen receptor antagonists to combat prostate cancer","volume":"8","author":"Yu","year":"2023","journal-title":"ACS Omega"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7.","DOI":"10.1038\/srep42717"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"W432","DOI":"10.1093\/nar\/gkae298","article-title":"admetSAR3.0: A comprehensive platform for exploration, prediction and optimization of chemical ADMET properties","volume":"52","author":"Gu","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/21\/4210\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:27:50Z","timestamp":1761712070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/21\/4210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":53,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["molecules30214210"],"URL":"https:\/\/doi.org\/10.3390\/molecules30214210","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}